|
| 1 |
The effects of immune checkpoint modulators on the clinical course of patients with resectable hepatocellular carcinoma
Jihyun An, Hyo Jeong Kang, Eunsil Yu, Han Chu Lee, Ju Hyun Shim
|
|
| 2 |
Fatty acid synthetase expression in triple-negative breast cancer
Jin Hee Park, Hye Seung Han, So Dug Lim, Wook Youn Kim, Kyoung Sik Park, Young Bum Yoo, Seung Eun Lee, Wan-Seop Kim
|
|
| 3 |
The Role of Neutrophil-to-Lymphocyte Ratio in Predicting Pathological Response for Resectable Non–Small Cell Lung Cancer Treated with Neoadjuvant Chemotherapy Combined with PD-1 Checkpoint Inhibitors
Xiaoyan Sun, Yingnan Feng, Bin Zhang, Wuhao Huang, Xiaoliang Zhao, Hua Zhang, Dongsheng Yue, Changli Wang
Cancer Res Treat.2022;54(4):1017-1029. Published online 2021 November 23
DOI: http://dx.doi.org/10.4143/crt.2021.1007
|
|
| 4 |
Clinicopathologic implication of PD-L1 gene alteration in primary adrenal diffuse large B cell lymphoma
Ki Rim Lee, Jiwon Koh, Yoon Kyung Jeon, Hyun Jung Kwon, Jeong-Ok Lee, Jin Ho Paik
|
|
| 5 |
Programmed death-ligand 1 expression and tumor-infiltrating lymphocytes in non-small cell lung cancer: association with clinicopathologic parameters
Gaurav Garg, Kuruswamy Thurai Prasad, Navneet Singh, Parul Gupta, Valliappan Muthu, Ashim Das, Amanjit Bal
|
|
| 6 |
Advances in immune checkpoint inhibitors for hepatocellular carcinoma
Ji Won Han, Su-Hyung Park
J Liver Cancer.2021;21(2):139-145. Published online 2021 September 30
DOI: http://dx.doi.org/10.17998/jlc.2021.09.24
|
|
| 7 |
Engineering a High-Affinity PD-1 Peptide for Optimized Immune Cell–Mediated Tumor Therapy
Yilei Chen, Hongxing Huang, Yin Liu, Zhanghao Wang, Lili Wang, Quanxiao Wang, Yan Zhang, Hua Wang
Cancer Res Treat.2022;54(2):362-374. Published online 2021 August 3
DOI: http://dx.doi.org/10.4143/crt.2021.424
|
|
| 8 |
Usefulness of Post-bronchoscopy Sputum Culture for Diagnosis of Nontuberculous Mycobacterial Pulmonary Disease
Kang-Mo Gu, Hye-Rin Kang, Jimyung Park, Nakwon Kwak, Jae-Joon Yim
|
|
| 9 |
Cardiac Toxicities Associated with Immune Checkpoints Inhibitors: Mechanisms, Manifestations and Management
Abdulrazzak Zarifa, Jin Wan Kim, Juan Lopez-Mattei, Nicolas Palaskas, Cezar Iliescu, Peter Y. Kim
Korean Circ J.2021;51(7):579-597. Published online 2021 May 21
DOI: http://dx.doi.org/10.4070/kcj.2021.0089
|
|
| 10 |
Immune Checkpoint Programmed Cell Death Protein-1 (PD-1) Expression on Bone Marrow T Cell Subsets in Patients With Plasma Cell Myeloma
Min Young Lee, Chan-Jeoung Park, Young-Uk Cho, Eunkyoung You, Seongsoo Jang, Eul Ju Seo, Jung-Hee Lee, Dok Hyun Yoon, Cheolwon Suh
|
|
| 11 |
Clinical Experience of Male Primary Choriocarcinoma at the Samsung Medical Center
Young Sok Ji, Se Hoon Park
Cancer Res Treat.2021;53(3):874-880. Published online 2020 December 7
DOI: http://dx.doi.org/10.4143/crt.2020.1066
|
|
| 12 |
Antinociceptive role of neurotensin receptor 1 in rats with chemotherapy-induced peripheral neuropathy
Mei Yin, Yeo-Ok Kim, Jeong-Il Choi, Seongtae Jeong, Si-Ho Yang, Hong-Beom Bae, Myung-Ha Yoon
Korean J Pain.2020;33(4):318-325. Published online 2020 October 1
DOI: http://dx.doi.org/10.3344/kjp.2020.33.4.318
|
|
| 13 |
Infiltration of T Cells and Programmed Cell Death Ligand 1-expressing Macrophages as a Potential Predictor of Lenvatinib Response in Hepatocellular Carcinoma
Pil Soo Sung, Sung Woo Cho, Jaejun Lee, Hyun Yang, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
J Liver Cancer.2020;20(2):128-134. Published online 2020 September 30
DOI: http://dx.doi.org/10.17998/jlc.20.2.128
|
|
| 14 |
Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea
Sun Min Lim, Sang-We Kim, Byoung Chul Cho, Jin Hyung Kang, Myung-Ju Ahn, Dong-Wan Kim, Young-Chul Kim, Jin Soo Lee, Jong-Seok Lee, Sung Yong Lee, Keon Uk Park, Ho Jung An, Eun Kyung Cho, Tae Won Jang, Bong-Seog Kim, Joo-Hang Kim, Sung Sook Lee, Im-II Na, Seung Soo Yoo, Ki Hyeong Lee
Cancer Res Treat.2020;52(4):1112-1119. Published online 2020 May 15
DOI: http://dx.doi.org/10.4143/crt.2020.245
|
|
| 15 |
Prognostic value of programmed cell death ligand-1 expression in ovarian cancer: an updated meta-analysis
Jinlan Piao, Hyun Ji Lim, Maria Lee
|
|
| 16 |
Re-defining T-Cell Exhaustion: Subset, Function, and Regulation
Se Jin Im, Sang-Jun Ha
Immune Netw.2020;20(1):e2. Published online 2020 February 20
DOI: http://dx.doi.org/10.4110/in.2020.20.e2
|
|
| 17 |
Peripheral blood immune cell-based biomarkers in anti-PD-1/PD-L1 therapy
Kyung Hwan Kim, Chang Gon Kim, Eui-Cheol Shin
Immune Netw.2020;20(1):e8. Published online 2020 February 10
DOI: http://dx.doi.org/10.4110/in.2020.20.e8
|
|
| 18 |
Re-defining T-Cell Exhaustion: Subset, Function, and Regulation
Se Jin Im, Sang-Jun Ha
Immune Netw.2020;20(1):e2. Published online 2020 February 4
DOI: http://dx.doi.org/10.4110/in.2020.20.e2
|
|
| 19 |
Peripheral Blood Immune Cell-based Biomarkers in Anti-PD-1/PD-L1 Therapy
Kyung Hwan Kim, Chang Gon Kim, Eui-Cheol Shin
Immune Netw.2020;20(1):e8. Published online 2020 February 4
DOI: http://dx.doi.org/10.4110/in.2020.20.e8
|
|
| 20 |
PD-1: A Negative Regulator of Phagocytosis by Tumour-Associated Macrophages in Colon Cancer
Mst Shanta Islam Tultul, Young-Sang Koh
|
|
